GetTopicDetailResponse(id=90ff123940c1, topicName=雙相障礙（BD）, introduction=, content=第二代抗精神病藥 雙相障礙（BD）, image=null, comments=0, allHits=134, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Tue Feb 04 11:18:50 CST 2025, time=2025-02-04, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=501118, tagList=[TagDto(tagId=501118, tagName=雙相障礙（BD）)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2250449, encodeId=87c82250449ca, content=<a href='/topic/show?id=bb34e5804a0' target=_blank style='color:#2F92EE;'>#第二代抗精神病藥#</a> <a href='/topic/show?id=90ff123940c1' target=_blank style='color:#2F92EE;'>#雙相障礙（BD）#</a>, objectTitle=JAACAP：第二代抗精神病藥物與情緒穩(wěn)定劑治療兒童和青少年急性躁狂癥的療效與安全性, objectType=article, longId=861902, objectId=5677861902a0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240713/1720839427878_5579292.png, objectUrl=/article/show_article.do?id=5677861902a0, replyNumber=0, likeNumber=32, createdTime=2025-02-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=5677861902a0, moduleTitle=JAACAP：第二代抗精神病藥物與情緒穩(wěn)定劑治療兒童和青少年急性躁狂癥的療效與安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5677861902a0)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-02-04發(fā)表于陜西省
